AstraZeneca Deepens China Cell Therapy Push - Top-Institutions - MDSpire

AstraZeneca Deepens China Cell Therapy Push

New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration

  • March 31, 2026

  • 2 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Cell Therapy
    • CAR-T Therapy
    • Hematology-Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Cell Therapy
    • Immunotherapy
    • Oncology

  • #3

    Zhejiang University School of Medicine
    Zhejiang University School of Medicine

    Hangzhou, Zhejiang Province

    Key Differentiators

    • Cell Therapy
    • Hematology
    • Immunotherapy

  • #4

    King's College London
    King's College London

    London, England

    Key Differentiators

    • Cell Therapy
    • Immunology
    • Translational Medicine

  • #5

    Gracell Biotech
    Gracell Biotech

    Shanghai, Shanghai

    Key Differentiators

    • Cell Therapy
    • CAR-T Development
    • Biopharmaceutical Manufacturing

Original Source(s)

AstraZeneca Deepens China Cell Therapy Push

  • March 31, 2026

Related Content

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study

Financial toxicity as logistical and relational burden across the lifespan during autologous transplant preparation

Efficacy of Quadruplet Therapy with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone as Initial Treatment for High-Risk Multiple Myeloma Patients in China: Findings from a Multi-Center Real-World Study